Cytek Biosciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $51,500 | $46,617 | $44,860 | $58,233 |
Gross Profit | 29,005 | 25,436 | 23,013 | 33,048 |
EBITDA | 3,083 | -4,572 | -6,092 | 2,288 |
EBIT | 274 | -7,052 | -8,552 | -137 |
Net Income | 941 | -10,434 | -6,169 | 5,503 |
Net Change In Cash | 51,500 | 46,617 | 44,860 | 58,233 |
Free Cash Flow | 12,413 | 5,003 | 3,335 | 7,951 |
Cash | 162,272 | 177,918 | 169,141 | 167,630 |
Basic Shares | 132,785 | 131,440 | 130,920 | 130,714 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $193,015 | $164,036 | $127,950 | $92,839 |
Gross Profit | 109,426 | 100,974 | 79,144 | 51,710 |
EBITDA | -4,407 | 9,535 | 10,399 | 15,366 |
EBIT | -13,637 | 3,833 | 9,157 | 14,763 |
Net Income | -12,148 | 2,576 | 4,417 | 19,411 |
Net Change In Cash | 193,015 | 164,036 | 127,950 | 92,839 |
Cost of Revenue | -62,627 | 197,196 | ||
Free Cash Flow | 454 | -22,099 | 266 | 13,609 |
Cash | 167,299 | 296,601 | 364,618 | 165,231 |
Basic Shares | 135,283 | 138,562 | 133,749 | 132,993 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.05 |
2024-06-30 | -$0.08 |
2024-03-31 | -$0.05 |
2023-12-31 | $0.04 |
